Hengrui Pharmaceuticals Gets Nod to Trial Tablets to Treat Uterine Fibroids With Menorrhagia
Hengrui Pharmaceuticals Gets Nod to Trial Tablets to Treat Uterine Fibroids With Menorrhagia
恒瑞药业获批试验治疗子宫肌瘤和月经过多的片剂
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册